Viewing nowCombinationNuborojet Tablet 40/2.5/10/10 Milligrams
Rosuvastatin Calcium Micronized 10.4mg · Ezetimibe 10mg +2 more
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.

MFDS item code 202203010 · Approved 2022.07.20 · Insurance code 643309090
Treatment of essential hypertension and dyslipidemia (hypercholesterolemia, etc.)
This drug is used for patients who are being treated for hypertension and dyslipidemia simultaneously. It is especially prescribed for patients with essential hypertension whose blood pressure is not adequately controlled even while receiving telmisartan/s-amlodipine combination therapy, and for dyslipidemia patients who require additional treatment while using rosuvastatin/ezetimibe combination therapy. This drug effectively lowers cholesterol levels and increases good cholesterol (HDL-C), helping to improve cardiovascular health. Therefore, it is a useful therapeutic option for managing both hypertension and hyperlipidemia.
This medicine is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the telmisartan/s-amlodipine (amlodipine) combination and the rosuvastatin/ezetimibe combination. The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. Take this medicine whole; do not chew, split, or crush it. ○ Telmisartan/s-amlodipine (amlodipine) The recommended dose of the telmisartan/s-amlodipine (amlodipine) combination is once daily. It is recommended that the dose be adjusted using the individual components (telmisartan or s-amlodipine (amlodipine)) before administering the telmisartan/s-amlodipine (amlodipine) combination. However, if blood pressure is not controlled with the individual components, switching directly to the telmisartan/s-amlodipine (amlodipine) combination may be considered as follows. - 40/2.5 milligrams: For patients whose blood pressure is not adequately controlled with s-amlodipine 2.5 milligrams (amlodipine 5 milligrams) or telmisartan 40 milligrams. - 80/2.5 milligrams: For patients whose blood pressure is not adequately controlled with s-amlodipine 2.5 milligrams (amlodipine 5 milligrams). - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with telmisartan 40 milligrams or 80 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with telmisartan 80 milligrams or this medicine 40/5 milligrams. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Elderly patients: In patients aged 75 years or older, amlodipine clearance is reduced; therefore, initiate treatment at a low dose and increase the dose gradually. ○ Rosuvastatin/ezetimibe Patients should continue a standard cholesterol-lowering diet before and during treatment with the rosuvastatin/ezetimibe combination. The dose of the rosuvastatin/ezetimibe combination should be adjusted according to the patient's baseline LDL-cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dosage range of the rosuvastatin/ezetimibe combination is 5/10mg∼20/10mg once daily. The recommended initial dose is 5/10mg once daily. For patients who require a greater reduction in LDL-cholesterol, the dose may be adjusted. After starting treatment with the rosuvastatin/ezetimibe combination or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly; the dose may be increased to a maximum of 20/10mg daily. Patients taking the telmisartan/s-amlodipine (amlodipine) combination together with the rosuvastatin/ezetimibe combination may switch to this medicine (a combination containing the same amounts of each active ingredient) for convenience.
This drug can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so women who are pregnant or planning to become pregnant should not take it. If there are symptoms such as muscle issues, muscle pain, muscle cramps, or muscle weakness, notify your doctor immediately and discontinue the medication. Patients with severely impaired liver or kidney function should not take this drug, while those with mildly impaired liver or kidney function should take it under careful observation by a physician. Patients with a history of allergic reactions to this drug or similar components should not take it. Regular liver function tests and muscle-related tests should be conducted during the use of this drug, and if any abnormal symptoms appear, immediate consultation with healthcare professionals is necessary. Patients with excessively low blood pressure or severe heart disease should not take this drug and should seek treatment if symptoms of hypotension occur. This drug may interact with other medications; therefore, you must inform your doctor or pharmacist of any other medications currently being taken. Caution is advised while driving or operating machinery, as dizziness or drowsiness may occur. This drug contains lactose; therefore, patients with lactose intolerance should not take it. During treatment with this drug, appropriate contraception should be maintained, and if pregnancy is confirmed, the medication should be stopped immediately and consult healthcare professionals.
Increased ALT, Increased AST, Increased Ɣ-GTP, Edema, Orthostatic hypotension, Hyperkalemia, Facial edema, Strange feeling, Drug intolerance, Colonic polyps, Irritable bowel syndrome, Esophagitis, Dizziness, Somnolence, Neurodegenerative disorders, Postural dizziness, Migraine, Diabetes, Impaired glucose tolerance, Depression, Bronchitis, Rhinitis, Cystitis, Onychomycosis, Soft tissue infection, Hepatic steatosis, Liver disturbances, Hepatotoxicity, Acute hepatitis, Toxic hepatitis, Increased gamma-glutamyl transferase, Increased blood cholesterol, Increased alkaline phosphatase, Irregular heart rate, Osteoarthritis, Osteoporosis, Musculoskeletal stiffness, Musculoskeletal discomfort, Muscle weakness, Sweating, Dermatitis, Skin burning sensation, Skin disorders, Alopecia, Oropharyngeal pain, Nasal congestion, Respiratory distress, Pelvic pain, Breast cysts, Eyelid drooping, Diabetic retinopathy, Ear discomfort, Renal dysfunction, Benign esophageal neoplasm, Upper respiratory tract infection, Urinary tract infection, Sepsis, Anemia, Thrombocytopenia, Eosinophilia, Hypersensitivity, Anaphylactic reaction, Hypoglycemia, Insomnia, Anxiety, Syncope, Visual disturbances, Dizziness, Bradycardia, Tachycardia, Dyspnea, Abdominal pain, Diarrhea, Dyspepsia, Abdominal distension, Vomiting, Abdominal discomfort, Dry mouth, Abnormal liver function, Liver disorders, Increased sweating, Pruritus, Rash, Erythema, Angioedema, Drug rash, Toxic dermatitis, Eczema, Urticaria, Myalgia, Back pain, Muscle cramps, Arthralgia, Limb pain, Tendon pain, Acute renal failure, Chest pain, Asthenia, Influenza-like illness, Increased serum creatinine, Increased serum uric acid, Elevated serum creatine kinase, Decreased hemoglobin, Headache, Facial spasms, Sensory abnormalities, Paralysis, Hyperventilation, Pneumonia, Flushing, Erectile dysfunction, Decreased appetite, Arrhythmia, Asthenic condition, Decreased libido, Facial edema, Alopecia, Conjunctivitis, Tinnitus, Petechiae, Hyperhidrosis, Purpura, Skin discoloration, Toxic epidermal necrolysis, Changes in bowel habits, Gingival hypertrophy, Pancreatitis, Epigastric pain, Loose stools, Constipation, Increased tension, Sensory loss, Peripheral neuropathy, Taste disturbances, Tremor, Extrapyramidal disturbances, Gynecomastia, Myocardial infarction, Arrhythmia, Sinoatrial block, Atrioventricular block, Abdominal discomfort, Heaviness, Sensation of heat, Impaired glucose tolerance, Weakness, Constipation, Nausea, Decreased appetite, Abdominal bloating, Syncope, Generalized pain, Muscle cramps, Gout, Joint pain, Myopathy, Myositis, Rhabdomyolysis, Immune-mediated necrotizing myopathy, Polyneuropathy, Amnesia, Peripheral neuropathy, Diarrhea, Stevens-Johnson syndrome, Eosinophilia and systemic symptoms-related drug reaction syndrome, Lupus-like syndrome, Muscle rupture, Hematuria, Edema, Anaphylaxis, Urticaria, Rash, Angioedema, Erythema multiforme, Increased creatine phosphokinase levels, Elevated liver aminotransferase levels, Hepatitis, Cholelithiasis, Cholecystitis
Not everyone experiences these, and they can vary from person to person.
Store this drug in a tightly closed container to protect it from air and moisture. It is advisable to maintain a storage temperature between 1 to 30 degrees Celsius at room temperature. This will help preserve the effectiveness of the medication for a long time.
Pale blue oval film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationRosuvastatin Calcium Micronized 10.4mg · Ezetimibe 10mg +2 more
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationTelmisartan 40mg · Rosuvastatin Calcium Micronized 5.2mg +2 more
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationTelmisartan 40mg · Rosuvastatin Calcium Micronized 5.2mg +2 more
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationTelmisartan 40mg · Rosuvastatin Calcium Micronized 10.4mg +2 more
Tablet · Prescription medication · Combination
Jonggeun Dang Co., Ltd.
CombinationTelmisartan 80mg · Rosuvastatin Calcium Micronized 10.4mg +2 more
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationTelmisartan 80mg · Rosuvastatin Calcium Micronized 5.2mg +2 more
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.